Health committee  The transition from research to translation or application in children is also a place where we could make the same comment about weakness. A major improvement could have been made for RSV infections, but it was blocked because we needed a company to make something special that d

Health committee  It's a bit far from my expertise, but what I would say as a citizen maybe and from my reading of the literature on the benefits, not my direct expertise, is that I agree with you that lifestyle impacts the diseases that we see in others, but it's a lifelong story and everything w

Health committee  I can begin. I completely agree with Dr. Quach‑Thahn. There was concern about resistance to antibiotics long before the COVID‑19 pandemic. This should be a research priority in order to find alternatives to antibiotics. I believe Canada has already invested in this in the past.

Health committee  Thank you for the question. It is true. There have been a lot of committees in place—for example, in the U.S., Europe, Belgium and France—to discuss what the standard should be. We already have standards that exist from different organizations. Experts in ventilation could defi

Health committee  Yes, two things. First, it is true that we would not have been able to fight COVID‑19 as we did without all the basic research on viruses, mRNAs, and vaccines that was done in advance. Because of that research, we were able to respond more quickly when the pandemic hit. Basic re

Health committee  I think there are many aspects. I think the health of children has been overlooked overall, as my colleagues described. It's a limited impact. I can only take the example of respiratory syncytial virus, on which we heard a lot. I have been working on that for 20 years now. It wa

Health committee  Thank you for the question. You have said it right. Obesity and diabetes were recognized as factors for vulnerability to COVID-19 very early on, in the beginning of the pandemic. These are definitely comorbidities that are impacting the immune system. That's not in terms of the

Health committee  Thank you, Mr. Chair. Mr. Chair, committee members and witnesses, thank you for this opportunity to appear as a full professor from the Université de Montréal and director of the host-virus interaction laboratory at the CRCHUM, Montreal. I am the co‑founder of Quebec's COVID pa

Health committee  I know the system exists to collect this data, but I don't know if they are connected, and if people are trying to connect data at the moment in Quebec.

Health committee  Yes. When you change the dosing like that, it means that you ask the people to take medication, or a vaccine in this case, in a different posology. You have to assess the risk and the benefit in these cases. When you give that to a patient, you have to inform them in detail of

Health committee  Well, no, and I don't think they are. They are just delayed. They are coming weeks after the decisions.

Health committee  No. In my opinion, that should happen immediately.

Health committee  No, there is no confidentiality, because there was no decision on which vaccine...that contract confidentiality.

Health committee  We cannot exclude this possibility.

Health committee  No, I don't think so.